Loading...

Nivolumab in the treatment of metastatic squamous non-small cell lung cancer: a review of the evidence

Progress in the treatment of patients with advanced stage squamous cell non-small cell lung cancer (NSCLC) has been limited. An improvement in the understanding of tumor immunosurveillance has resulted in the development of the immune checkpoint inhibitors such as nivolumab. Nivolumab (Opdivo(®)), a...

Full description

Saved in:
Bibliographic Details
Published in:Ther Adv Respir Dis
Main Authors: Lim, Joline S. J., Soo, Ross A.
Format: Artigo
Language:Inglês
Published: SAGE Publications 2016
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5933620/
https://ncbi.nlm.nih.gov/pubmed/27480166
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1753465816661091
Tags: Add Tag
No Tags, Be the first to tag this record!